Skip to main content
. 2022 Dec 1;10(12):e005651. doi: 10.1136/jitc-2022-005651

Figure 1.

Figure 1

HLA-I immunopeptidomes of HROC113 and HROC285. (A) Total number of identified conventional (CDS) and cryptic HLA-I peptides with and without IFNγ treatment (false discovery rate: <10%, NetMHCpan rank: <2%). (B) Identified cryptic peptides identified from HROC113 and HROC285 by category. HLA peptides were assigned to the HLA allele with the lowest rank value. (C) Identified neoantigens derived from non-synonymous SNVs. SNVs, single-nucleotide variants.